{
  "ticker": "KROS",
  "success": true,
  "price": {
    "current": 17.99,
    "currency": "USD",
    "day_high": 18.1873,
    "day_low": 17.81,
    "52_week_high": 22.55,
    "52_week_low": 9.12
  },
  "market_cap": {
    "value": 548084544.0,
    "currency": "USD"
  },
  "shares_outstanding": 30466069.0,
  "volume": {
    "last": 201573,
    "average_30d": 349670
  },
  "valuation": {
    "pe_ratio": 11.532051,
    "forward_pe": -6.1160727,
    "price_to_book": 1.0389235
  },
  "company_info": {
    "name": "Keros Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 742783000.0,
    "total_liabilities": 39203000.0,
    "stockholders_equity": 703580000.0,
    "cash": 693472000.0,
    "marketable_securities": null,
    "total_liquidity": 693472000.0,
    "total_debt": 17429000.0,
    "long_term_debt": 15111000.0,
    "current_debt": 2318000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": 3249000.0,
    "free_cash_flow": 3117000.0,
    "investing_cash_flow": -132000.0,
    "financing_cash_flow": 140000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 29646000.0,
    "research_and_development": 19519000.0,
    "interest_expense": null,
    "net_income": -7280000.0,
    "revenue": 14262000.0,
    "gross_profit": null,
    "ebitda": -14989000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:48:44.970391",
    "url": "https://finance.yahoo.com/quote/KROS",
    "data_hash": "37aafa5104e0fcd1"
  }
}